InvestorsHub Logo

Wildginger

03/02/18 10:51 PM

#5878 RE: Whatsupp #5877

While not a fan of AF about a year ago he mentioned how they just keep kicking the can down the road. Much more validated peer work here. IMO

XenaLives

03/02/18 11:03 PM

#5880 RE: Whatsupp #5877

Dr. Missling has a relatively modest wage as industry standards go. He is taking options - and placing his bets alongside shareholders.

They didn't "promise" to start several trials... they expected to do so. CNS guidance was just released within the last month. Big Pharma has been abandoning CNS trials like rats leaving a sinking ship.

Anavex is tuned into the changes at the FDA and will benefit, IMO.